Female Pelvic Med Reconstr Surg
December 2017
Acta Crystallogr Sect F Struct Biol Cryst Commun
September 2011
Acta Crystallogr Sect F Struct Biol Cryst Commun
September 2011
The enzyme thymidylate kinase phosphorylates the substrate thymidine 5'-phosphate (dTMP) to form thymidine 5'-diphosphate (dTDP), which is further phosphorylated to dTTP for incorporation into DNA. Ehrlichia chaffeensis is the etiologic agent of human monocytotropic erlichiosis (HME), a potentially life-threatening tick-borne infection. HME is endemic in the United States from the southern states up to the eastern seaboard.
View Article and Find Full Text PDFActa Crystallogr Sect F Struct Biol Cryst Commun
September 2011
Giardia lamblia is the etiologic agent of giardiasis, a water-borne infection that is prevalent throughout the world. The need for new therapeutics for the treatment of giardiasis is of paramount importance. Owing to the ubiquitous nature of kinases and their vital importance in organisms, they are potential drug targets.
View Article and Find Full Text PDFActa Crystallogr Sect F Struct Biol Cryst Commun
September 2011
Acta Crystallogr Sect F Struct Biol Cryst Commun
September 2011
Acta Crystallogr Sect F Struct Biol Cryst Commun
September 2011
The recombinant expression of soluble proteins in Escherichia coli continues to be a major bottleneck in structural genomics. The establishment of reliable protocols for the performance of small-scale expression and solubility testing is an essential component of structural genomic pipelines. The SSGCID Protein Production Group at the University of Washington (UW-PPG) has developed a high-throughput screening (HTS) protocol for the measurement of protein recovery from immobilized metal-affinity chromatography (IMAC) which predicts successful purification of hexahistidine-tagged proteins.
View Article and Find Full Text PDFUltrafiltration provides a generic method to discover ligands for protein drug targets with millimolar to micromolar K(d), the typical range of fragment-based drug discovery. This method was tailored to a 96-well format, and cocktails of fragment-sized molecules, with molecular masses between 150 and 300 Da, were screened against medical structural genomics target proteins. The validity of the method was confirmed through competitive binding assays in the presence of ligands known to bind the target proteins.
View Article and Find Full Text PDF